Swedish diabetes startup Diasend merges with Silicon Valley competitor and raises $8.25 million

September 13th

Diasend have merged with their biggest competitor, U.S-based Glooko. Eventually they will operate under the Glooko brand, however the merger is an even one, with Diasend growing from 30 to 80 employees overnight. Samsung Ventures (among others) have subsequently invested in the 'new' company.

Full story: Breakit